JP2022552200A5 - - Google Patents

Info

Publication number
JP2022552200A5
JP2022552200A5 JP2022520980A JP2022520980A JP2022552200A5 JP 2022552200 A5 JP2022552200 A5 JP 2022552200A5 JP 2022520980 A JP2022520980 A JP 2022520980A JP 2022520980 A JP2022520980 A JP 2022520980A JP 2022552200 A5 JP2022552200 A5 JP 2022552200A5
Authority
JP
Japan
Application number
JP2022520980A
Other languages
Japanese (ja)
Other versions
JPWO2021071977A5 (https=
JP2022552200A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/054621 external-priority patent/WO2021071977A1/en
Publication of JP2022552200A publication Critical patent/JP2022552200A/ja
Publication of JP2022552200A5 publication Critical patent/JP2022552200A5/ja
Publication of JPWO2021071977A5 publication Critical patent/JPWO2021071977A5/ja
Pending legal-status Critical Current

Links

JP2022520980A 2019-10-07 2020-10-07 樹状細胞およびT細胞の活性化を増強するためのならびにTH-1免疫応答を誘導するためのin vitroの方法および組成物 Pending JP2022552200A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962912005P 2019-10-07 2019-10-07
US62/912,005 2019-10-07
PCT/US2020/054621 WO2021071977A1 (en) 2019-10-07 2020-10-07 In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response

Publications (3)

Publication Number Publication Date
JP2022552200A JP2022552200A (ja) 2022-12-15
JP2022552200A5 true JP2022552200A5 (https=) 2023-10-18
JPWO2021071977A5 JPWO2021071977A5 (https=) 2023-10-18

Family

ID=75437644

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520980A Pending JP2022552200A (ja) 2019-10-07 2020-10-07 樹状細胞およびT細胞の活性化を増強するためのならびにTH-1免疫応答を誘導するためのin vitroの方法および組成物

Country Status (11)

Country Link
US (1) US20240122975A1 (https=)
EP (1) EP4041298A4 (https=)
JP (1) JP2022552200A (https=)
KR (1) KR20220098351A (https=)
CN (1) CN115461073A (https=)
AU (1) AU2020363707A1 (https=)
BR (1) BR112022006743A2 (https=)
CA (1) CA3157004A1 (https=)
IL (1) IL292009A (https=)
MX (1) MX2022004186A (https=)
WO (1) WO2021071977A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180318414A1 (en) 2015-01-12 2018-11-08 Children's Medical Center Corporation Pro-Inflammatory and Adjuvant Functions of Toll-Like Receptor 4 Antagonists
JP7753205B2 (ja) * 2019-11-18 2025-10-14 ザ・チルドレンズ・メデイカル・センター・コーポレーシヨン 超活性樹状細胞は養子細胞移植に基づく持続性抗腫瘍免疫を可能にする
WO2024151124A1 (ko) * 2023-01-12 2024-07-18 주식회사 이뮤노맥스 항암능이 우수한 기억 t 세포 유래 면역세포치료제의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1636229B (zh) * 2001-09-06 2012-12-19 西北生物治疗药物公司 引发单核树突细胞和t细胞th-1应答的组合物和方法
US20180318414A1 (en) * 2015-01-12 2018-11-08 Children's Medical Center Corporation Pro-Inflammatory and Adjuvant Functions of Toll-Like Receptor 4 Antagonists
CN107849537A (zh) * 2015-06-30 2018-03-27 西北生物治疗药物公司 诱发改善的或增加的抗肿瘤免疫应答的经最佳活化的树突细胞
JP6980650B2 (ja) * 2015-09-15 2021-12-15 ノースウエスト バイオセラピューティクス,インコーポレイティド 進行したがんを有する被験体のための活性化樹状細胞組成物および免疫療法処置に関する方法

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
JP2022552200A5 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)